University of Alabama School of Medicine, Birmingham, AL, USA.
Division of Cardiovascular Medicine, Clemenceau Medical Center, Beirut, Lebanon.
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1998-2008. doi: 10.1007/s00259-018-4068-2. Epub 2018 Jun 7.
Noninvasive stress testing is commonly performed as part of pre-renal transplantation (RT) evaluation. We evaluated the prognostic value of myocardial perfusion imaging (MPI)-myocardial perfusion, left ventricular ejection fraction (LVEF) and heart rate response (HRR)-post-RT.
Consecutive RT recipients were identified at our institution. MPI was considered abnormal when there was a perfusion defect or reduced ejection fraction. HRR to vasodilator stress was calculated as percentage change from baseline. The primary outcome was a composite of cardiovascular (CV) death, myocardial infarction (MI) and coronary revascularization (CR) post-RT; all-cause mortality was the secondary endpoint.
Among 1189 RT recipients, 819 (69%) underwent MPI. Of those, 182 (22%) had abnormal MPI, and 31 (4%) underwent CR pre-RT. During a median follow-up of 56 months post-RT, the annual CV event and mortality rates for patients who had no MPI, normal MPI and abnormal MPI were 1.5%, 3.1% and 4.3% (p < 0.001), and 1.8%, 2.6% and 3.6% (p = 0.016), respectively. After multivariate adjustment, compared to patients without MPI, the hazard ratios (HRs) for CV events for normal and abnormal MPI were 1.47 ([0.93-2.33], p = 0.1) and 1.78 ([1.03-3.06], p = 0.04). Blunted HRR was an independent predictor of CV events (HR = 1.73 [1.04-2.86], p = 0.034) and all-cause death (HR = 2.26 [1.28-3.98], p = 0.005) after adjusting for abnormal MPI. Patients with abnormal MPI who underwent CR pre-RT had annual mortality rates similar to those with no or normal MPI (1.9% vs. 1.7-2.6%, p = 0.2), while those who did not undergo CR had higher annual mortality (4% vs. 1.7-2.6%, p = 0.003).
One in five RT recipients who underwent screening MPI had an abnormal study, an independent predictor of CV events. A blunted HRR to vasodilator stress was associated with increased risk of CV events and death, even after adjusting for abnormal MPI. Patients with abnormal MPI who underwent CR were at low risk of mortality following RT. MPI is a useful tool to aid in risk stratification pre-RT.
在肾移植(RT)前评估中,通常进行非侵入性应激测试。我们评估了 RT 后心肌灌注成像(MPI)-心肌灌注、左心室射血分数(LVEF)和心率反应(HRR)的预后价值。
在我们的机构中确定了连续的 RT 受者。当存在灌注缺陷或射血分数降低时,MPI 被认为异常。血管扩张剂应激后的 HRR 计算为与基线相比的百分比变化。主要结局是 RT 后心血管(CV)死亡、心肌梗死(MI)和冠状动脉血运重建(CR)的复合;全因死亡率为次要终点。
在 1189 名 RT 受者中,819 名(69%)接受了 MPI。其中,182 名(22%)MPI 异常,31 名(4%)在 RT 前接受了 CR。在 RT 后中位随访 56 个月期间,没有 MPI、MPI 正常和 MPI 异常的患者的 CV 事件和死亡率分别为每年 1.5%、3.1%和 4.3%(p<0.001)和 1.8%、2.6%和 3.6%(p=0.016)。经过多变量调整后,与没有 MPI 的患者相比,MPI 正常和异常的 CV 事件的危险比(HR)分别为 1.47([0.93-2.33],p=0.1)和 1.78([1.03-3.06],p=0.04)。HRR 减弱是 CV 事件(HR=1.73 [1.04-2.86],p=0.034)和全因死亡(HR=2.26 [1.28-3.98],p=0.005)的独立预测因子,在调整异常 MPI 后。在 RT 前接受 CR 的 MPI 异常患者的年死亡率与无 MPI 或 MPI 正常的患者相似(1.9%比 1.7-2.6%,p=0.2),而未接受 CR 的患者的年死亡率较高(4%比 1.7-2.6%,p=0.003)。
接受筛查 MPI 的 RT 受者中有五分之一存在异常研究,这是 CV 事件的独立预测因子。血管扩张剂应激后的 HRR 减弱与 CV 事件和死亡风险增加相关,即使在调整了异常 MPI 后也是如此。在 RT 后接受 CR 的 MPI 异常患者的死亡率较低。MPI 是 RT 前进行风险分层的有用工具。